Kailera Therapeutics, Inc. (KLRA)
15.82
-0.59
(-3.60%)
USD |
NASDAQ |
Sep 02, 16:00
15.82
0.00 (0.00%)
After-Hours: 18:34
Kailera Therapeutics Research and Development Expense (Annual) : 109.11M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 109.11M |
| Date | Value |
|---|---|
| December 31, 2024 | 6.975M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Moderna, Inc. | 2.917B |
| Revolution Medicines, Inc. | 978.68M |
| Sana Biotechnology, Inc. | 133.91M |
| Parabilis Medicines, Inc. | 125.01M |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |